Chatsworth Pharmaceuticals LLC is categorized under Wholesale Pharmaceutical Products in Calabasas, CA and active since 2011.
Chatsworth Pharmaceuticals LLC was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Frank Loffa at the company’s single location by writing to 5337 Newcastle Lane, Calabasas, California CA 91302 or by phoning (818) 880-8101. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Chatsworth Pharmaceuticals LLC |
| Contact Person: | Frank Loffa |
| Address: | 5337 Newcastle Lane, Calabasas, California 91302 |
| Phone Number: | (818) 880-8101 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Wholesale Pharmaceutical Products |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Chatsworth Pharmaceuticals LLC was started in 2011 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Frank Loffa for inquiries that concern Chatsworth Pharmaceuticals LLC by calling the company number (818) 880-8101, as your correspondence is most welcome. Additionally, the physical location of the single location of Chatsworth Pharmaceuticals LLC can be found at the coordinates 34.158298,-118.681194 as well as the street address 5337 Newcastle Lane in Calabasas, California 91302.
For its online presence, you may visit Chatsworth Pharmaceuticals LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.